SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

BioAmber, Inc. (BIOA)

BIOA RSS Feed
Add BIOA Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 9/3/2016 4:38:25 PM - Followers: 5 - Board type: Free - Posts Today: 0

)=( BioAmber)=(

http://www.bio-amber.com/


biopy.jpg


Set to IPO

The common stock and warrants comprising the units will begin trading separately on NYSE under the symbols "BIOA" and "BIOA.WS", respectively, on Monday, June 10, 2013 at which time trading of the units will be suspended and the units will be delisted. BioAmber also intends to list its common stock on the Professional Segment of the regulated market of NYSE Euronext in Paris under the symbol "BIOA".



 
http://www.nasdaq.com/markets/ipos/company/bioamber-inc-867818-68605



Offer Amount - $80,000,000

Share Price - $10


Shares Outstanding - 18,412,815

Shares Offered - 8,000,000

Lockup Period - 180 days


We are a next-generation chemicals company. Our proprietary technology platform
combines industrial biotechnology and chemical catalysis to convert renewable
feedstocks into sustainable chemicals that are cost-competitive replacements for
petroleum-derived chemicals. We currently sell our first

product, bio-succinic
acid, to customers in a variety of chemical markets. We intend to produce
bio-succinic acid that is cost-competitive with succinic acid produced from
petroleum at our planned facility in Sarnia, Ontario. We currently produce our
bio-succinic acid in a large-scale demonstration facility using a 350,000 liter
fermenter in Pomacle, France, which we believe to be among the largest bio-based
chemical manufacturing facilities in the world. We have produced approximately
1.25 million pounds, or 568 metric tons, of bio-succinic acid at this facility
as of December 31, 2012. We sold 144,500 pounds and 356,900 pounds of
bio-succinic acid to our customers in the years ended December 31, 2011 and
December 31, 2012, respectively.

We have achieved a number of accomplishments through the successful
implementation of our proprietary technology platform including:

• a history of large scale fermentation and continuous purification;

• low-cost bio-succinic acid production capability;

• a customer-qualified manufacturing process;

• supply agreements with large and established customers;

• an equity partnership for our first global scale biochemical manufacturing
facility; and

• multiple commercial and exclusive technology partnerships.

Succinic acid can be used to manufacture a wide variety of products used every
day, including plastics, food additives and personal care products, and can also
be used as a building block for a number of derivative chemicals. Today,
petroleum-derived succinic acid is not used in many potential applications
because of its relatively high production costs and selling price. We believe
that our low-cost production capability and our development of next-generation
bio-succinic derived products including 1,4 butanediol, or 1,4 BDO, which is
used to produce polyesters, plastics, spandex and other products, will provide
us with access to a more than $10 billion market opportunity. Combining these
opportunities with other building block chemicals we are developing, including
adipic acid and caprolactam, which are used in the production of nylons, we
believe that our total addressable market is in excess of $30 billion.

We believe we can produce bio-succinic acid that is cost-competitive with
succinic acid produced from oil priced as low as $35 per barrel, based on
management's estimates of production costs at our planned facility in Sarnia,
Ontario and an assumed corn price of $6.50 per bushel. While we can provide no
assurance that we will be able to secure corn at $6.50 per bushel given the
fluctuations in corn prices, we believe this assumption is reasonable given the
historic price of corn and management's expectations as to their ability to
manage the cost of corn and other inputs for our planned facility in Sarnia,
Ontario. Over the past five years, the price of corn ranged from a low of $2.68
per bushel to a high of $8.44 per bushel. As of April 1, 2013, the spot price
was $6.55 per bushel and the six month forward price was $5.51 per bushel. We
estimate that a $1.00 increase or decrease in the per bushel price of corn would
result in just a $0.024 per pound change in our variable cost of our
bio-succinic acid. We expect the productivity of the organism used in our
fermentation process and other on-going process improvements to further reduce
our production costs. Our ability to compete on cost is not dependent on
government subsidies or tariffs.

We are working to rapidly expand our accessible markets and product
portfolio. We have entered into strategic relationships with several leading
companies, such as our multi-year agreement with Mitsubishi Chemical
Corporation, or Mitsubishi Chemical, for bio-succinic acid. We have also entered
into agreements with LANXESS Deutschland GmbH, or Lanxess, Faurecia, S.A., or
Faurecia, NatureWorks LLC, or NatureWorks, and others for the development of
derivatives of bio-succinic acid.

We have also entered into technology partnerships to lower our production costs,
expand our product portfolio and enhance our biochemical production platform.
For example, we entered into a technology partnership with Cargill Inc., or
Cargill, through which we exclusively license a proprietary yeast organism for
use in our fermentation process to produce our products. Throughout this
prospectus, we refer to the yeast organism that we have licensed from Cargill as
"our yeast." We have also established other technology licenses and
collaborations, including with E.I. du Pont de Nemours and Company, or DuPont,
Evonik Industries AG, or Evonik, Agro-industrie Recherches et Développements, or
ARD, Celexion, LLC, or Celexion, and entities funded by the U.S. Department of
Energy, or DOE.

Our business strategy is to leverage the value of our technology by building and
operating production facilities around the world. However, depending on our
access to capital and third-party demand for our technology, we may also enter
into technology licenses on an opportunistic basis.

In order to support our growth strategy, we have begun to rapidly expand our
manufacturing capacity. We have entered into a joint venture agreement with
Mitsui & Co., Ltd., or Mitsui, for our planned facility in Sarnia, Ontario,
which has an initial projected capacity of 30,000 metric tons of bio-succinic
acid and could subsequently be expanded to produce another 20,000 metric tons of
bio-succinic acid. A portion of our aggregate capacity could be further
converted to produce bio-based 1,4 BDO. As an example, we estimate that
approximately 30,000 metric tons of bio-succinic acid production could be
converted into approximately 22,000 metric tons of bio-based 1,4 BDO production.
We have commenced engineering and substantially completed permitting for this
facility and the initial phase is expected to be mechanically complete in 2014.
By "mechanically complete," we mean that construction of the facility has been
substantially completed such that we can begin commissioning and start-up. We
expect this facility will be fully funded through equity contributions by both
us, with a portion of the net proceeds from this offering, and Mitsui, as well
as a combination of government grants and interest-free loans. As we commission
and start-up our planned facility in Sarnia, Ontario, we expect to terminate
production of our products at the large-scale demonstration facility in Pomacle,
France. Our joint venture with Mitsui also contemplates the potential
construction and operation of two additional facilities, which we expect to
occur over the next three to four years.

We are committed to managing our economic, social, environmental and ethical
performance through continued sustainable business practices. We have recently
completed a life cycle analysis for our planned facility in Sarnia that
indicates that only 0.04 kilograms of carbon dioxide equivalent (or greenhouse
gases) will be emitted per kilogram of our bio-succinic acid produced, making
our processes essentially carbon neutral. This is significantly less carbon
intensive than the current petrochemical process for making succinic acid, in
which 7.1 kilograms of carbon dioxide equivalent are emitted per kilogram of
succinic acid produced. This represents a 99.4% reduction in greenhouse gases
for our bio-succinic acid process, relative to the current petrochemical
process for making succinic acid. The life cycle analysis also indicates that
our planned facility in Sarnia will consume 56% less energy than the current
petrochemical process. The analysis also indicates that field-to-gate energy
use will be 42.7 mega joules per kilogram of our bio-succinic acid produced, as
compared to the current petrochemical process, which uses 97.7 mega joules per
kilogram of succinic acid produced.

We are a development stage company and recognized revenues from the sales of
products during the years ended December 31, 2011 and 2012. We incurred net
losses of $30.9 million and $39.5 million, respectively, during the years ended
December 31, 2011 and 2012. These losses are expected to continue as we further
develop our technologies and proprietary processes, build our operating
infrastructure, and provide customers with products for testing and verification
for their various end uses.

------

We were incorporated in the state of Delaware on October 15, 2008 as DNP Green
Technology, Inc. The core of our bio-succinic acid platform technology was
developed by entities funded by the DOE in the late 1990s, as part of its
Alternative Feedstocks Program, and is under exclusive license to us. Prior to
our incorporation, the bio-succinic acid technology was licensed to Diversified
Natural Products, Inc., or DNP. The technology was assigned to us as part of an
asset spin-off transaction in 2008 and 2009 in which certain assets of DNP were
assigned to BioAmber Inc. in exchange for shares of BioAmber Inc. These assets
included DNP's share in Bioamber S.A.S., a joint venture with ARD, the purpose
of which was to research bio-succinic acid and processes to produce
bio-succinic acid. In 2010, we acquired 100% of our joint venture with ARD and
changed our name to BioAmber Inc. In 2010, we also acquired 75% of Sinoven
BioPolymers Inc, or Sinoven, our wholly-owned subsidiary with proprietary
technology for modifying PBS, and acquired the remaining 25% interest in 2011.
In 2011, we created a wholly-owned Luxembourg entity, BioAmber International,
S.à.r.l., to hold certain intellectual property assets and BioAmber Sarnia Inc.
(f/k/a Bluewater BioChemicals Inc.), or BioAmber Sarnia, a joint venture with
Mitsui through which we will fund our planned facility in Sarnia, Ontario. We
retain 70% ownership of the BioAmber Sarnia joint venture. In 2012, we entered
into a series of agreements with NatureWorks to create AmberWorks, a joint
venture in which we have a 50% ownership interest.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BIOA
Current Price
Volume:
Bid Ask Day's Range
SureTrader
PostSubject
#37   BIOA bullish 4.03 stocktrademan 09/03/16 04:38:25 PM
#36   BIOA bullish 3.59 stocktrademan 08/16/16 10:18:53 AM
#35   OUT OF BIOA GREAT PLAY TY :-) NO BID 10/05/15 11:37:10 AM
#34   WEEEEEE BIOA NO BID 10/05/15 11:26:58 AM
#33   WE WILL NAME KEITH STONE ;-) NO BID 10/05/15 10:32:41 AM
#32   BRAVO FINALLY SOMEONE WITH A PAIR OF STONES BIOA NO BID 10/05/15 10:28:32 AM
#31   LETS GO VOLUME :-) BIOA FTW NO BID 10/05/15 09:46:31 AM
#30   GOOD NEWS EVERYONE!!! BIOA RUNNING HARD MONDAY!!! NO BID 10/03/15 07:42:00 PM
#29   BIOA FANTASTIC NEWS FRIDAY!!! COMPANY EXCEEDING THEIR OWN NO BID 10/03/15 03:10:11 PM
#28   BIOA LETS HAVE AN EPIC MONDAY :-) NO BID 10/03/15 03:01:08 PM
#27   BIOA OVERSOLD!!! BioAmber Sarnia Producing High Quality Bio-Succinic Acid NO BID 10/02/15 11:40:10 PM
#26   $8.40 TARGET PRICE FOR FREEMONEY :-) NO BID 10/02/15 08:33:58 PM
#25   WHO GOT SHOOOOK ??? NO BID 10/02/15 03:58:48 PM
#24   EOD SQQQQQQQQQQUUUUUUUEEEEEEZZZZZZEEEEEEEE WEEEEEEEEEEEE NO BID 10/02/15 03:39:34 PM
#23   WEEEEEEEE BIOA FTW NO BID 10/02/15 03:38:28 PM
#22   BOOOOOOM SQUUUUUUUUUEEEEEZZZEEEE DEM BITCHES WEEEEEEEE NO BID 10/02/15 03:19:01 PM
#21   BIOA BOUT TO GO BEASTMODE ~~>> http://youtu.be/1XrzTgvBd6Q NO BID 10/02/15 03:14:21 PM
#20   WEEEEEEE BIOA NO BID 10/02/15 03:05:51 PM
#19   GIDDY UP BIOA FTDUBYAH NO BID 10/02/15 02:49:37 PM
#18   $BIOA IN @ 6.44 ;-) NO BID 10/02/15 01:48:38 PM
#17   $BIOA recent news/filings stocktrademan 05/11/15 07:43:12 AM
#16   sorry wrong board John Gault 04/15/14 06:41:21 PM
#15   That IS NOT the ticker. I just hung John Gault 04/15/14 06:40:51 PM
#14   Looks like a great company John Gault 04/15/14 06:37:55 PM
#13   Yeah this one has just too little volume adeezl 06/20/13 01:20:51 AM
#12   ADEEZI; Is it Adeezi's barometer to decide when mlkrborn 06/19/13 04:03:47 PM
#11   Interesting one! mlkrborn 06/19/13 04:00:20 PM
#10   The lack of volume and spread are not adeezl 06/19/13 12:34:22 PM
#9   2 analyst upgrades here Outperform target $15 adeezl 06/18/13 12:25:42 PM
#8   Hah wow the bioa/u units have moved nicely adeezl 06/01/13 04:46:23 PM
#7   Well the BIOA/U units trade, but very little adeezl 05/24/13 03:55:24 AM
#6   I'm not totally sure what's up here folks adeezl 05/19/13 02:43:47 PM
#5   5/10/13 *Update Ticker Change? (It didn't open Friday adeezl 05/12/13 10:21:04 PM
#4   BioAmber prices 8 mln unit IPO consisting of mlkrborn 05/10/13 04:10:14 PM
#3   BioAmber Inc. (BIOA) Tuesday cut the expected adeezl 05/08/13 01:01:29 PM
#2   Nothing yet, didn't open Friday. The ticker changed adeezl 05/05/13 07:34:11 PM
#1   BIOA I likey.. want to buy on the adeezl 04/26/13 04:02:03 PM
PostSubject